4//SEC Filing
Coissac Patrice 4
Accession 0001231977-12-000076
CIK 0000899866other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:30 PM ET
Size
8.7 KB
Accession
0001231977-12-000076
Insider Transaction Report
Form 4
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
- Sale
Common Stock, par value $.0001 per share
2012-10-31$92.18/sh−12,030$1,108,925→ 1,118 total - Sale
Common Stock, par value $.0001 per share
2012-10-31$90.80/sh−33,546$3,045,977→ 52,336 total - Sale
Common Stock, par value $.0001 per share
2012-10-31$91.15/sh−39,188$3,571,986→ 13,148 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.00 - $90.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.00 - $91.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.00 - $92.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001341212
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:30 PM ET
- Size
- 8.7 KB